CD34 and coronary artery disorder: The safety and efficacy of intracoronary injection of autologous CD34+ stem cells in two concentrations (low-dose and high-dose) were evaluated in 38 patients with no option CAD and left ventricular dysfunction in a phase I randomized trial [79].